Results 121 to 130 of about 71,398 (199)

Safety through design: Expanding options for spinal muscular atrophy gene therapy. [PDF]

Mol Ther Methods Clin Dev
Groen EJN, Wadman RI.
europepmc   +1 more source

Surgical Access for Intrathecal Therapy in Spinal Muscular Atrophy with Spinal Fusion: Long-Term Outcomes of Lumbar Laminectomy. [PDF]

J Clin Med
Potaczek T, Duda S, Adamczyk J.
europepmc   +1 more source

Cerebrospinal fluid metabolomics reveals predictive biomarkers of nusinersen therapy efficacy in type II and type III spinal muscular atrophy patients. [PDF]

Neurol Sci
Li D, Sun N, Wu H, Wang X, Shi Y, Yang L, Huang S, Zhang K, Yang C.   +8 more
europepmc   +1 more source

Real-world outcomes of spinal muscular atrophy treatment with onasemnogene abeparvovec in Croatia: a comprehensive case series and literature review. [PDF]

Front Med (Lausanne)
Lehman I, Matošević M, Lamot L, Bunoza B.   +3 more
europepmc   +1 more source

Duraplasty with laminoplasty for Hirayama disease: a technical note with a case series. [PDF]

Asian Spine J
Farid F, Nakamae T, Fujimoto Y, Yamada K, Fujiwara Y, Fukui H, Adachi N.   +6 more
europepmc   +1 more source

Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1.

JAMA Netw Open
Ropars J, Cances C, Garcia-Uzquiano R, Gomez-Garcia de la Banda M, Barnerias C, Audic F, Durigneux J, Halbert C, Nkam L, Laugel V, Espil C, Walther-Louvier U, Davion JB, Isapof A, Le Goff L, Desguerre I, Quijano-Roy S, Grimaldi L, French SMA Registry Study Group.   +18 more
europepmc   +1 more source

Risdiplam treatment following onasemnogene abeparvovec in individuals with spinal muscular atrophy: a multicenter case series. [PDF]

BMC Neurol
Svoboda MD, Kuntz N, Leon-Astudillo C, Byrne BJ, Krueger J, Kwon JM, Sieburg C, Castro D.   +7 more
europepmc   +1 more source

Response to Fortin-Bédard et al. "User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational study". [PDF]

Neurol Res Pract
Spittel S, Meyer T, Weyen U, Grehl T, Weydt P, Steinbach R, Petri S, Baum P, Metelmann M, Sperfeld AD, Kettemann D, Norden J, Rödiger A, Ilse B, Grosskreutz J, Hildebrandt B, Walter B, Münch C, Maier A.   +18 more
europepmc   +1 more source

Myostatin Modulation in Spinal Muscular Atrophy: A Systematic Review of Preclinical and Clinical Evidence. [PDF]

Int J Mol Sci
Gnazzo M, Pisanò G, Baldini V, Giacomelli G, Scullin S, Piccolo B, Turco EC, Esposito S, Pera MC.   +8 more
europepmc   +1 more source

Persistent Jaw Drop Following Botulinum Injection as the Initial Clinical Manifestation of Spinal and Bulbar Muscular Atrophy. [PDF]

J Clin Neurol
Ju W, Min YG, Ahn SW, Sung JJ.
europepmc   +1 more source